Skip to content

HRTX - HERON THERAPEUTICS, INC. /DE/ - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchH

Heron Therapeuti

HRTX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

H

HRTXHeron Therapeuti

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $1.58
52-wk low: $0.30
Prev close: $1.03
Mkt cap: $59.8M
Fwd P/E: 47.0x
Beta: 1.67

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$11.0M

MI
Millennium
Israel Englander · Q2 2026 13F
$1.7M
position
MW
Marshall Wace
Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings came in $0.01 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -22.5%
Forward P/E: 46.95
Market cap: $60M

Valuation

P/S0.40
P/B9.75

Quality

Operating margin-5.4%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: HRTX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $59.78M
Beta: 1.67

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

0.4x

P/B

9.8x

Profit margin

-22.5%

Op margin

-5.4%

ROE

-2409.0%

$1.0M

position

AQ

AQR

Q2 2026 13F

$663K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for HRTX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.03-$0.01

-$0.02 expected

Next report

What the street expects next

EPS expected

-$0.02

-$0.02 to -$0.02

Revenue expected

$37.4M

1 analysts

ROE

-2409.0%

ROA-2.8%

Growth

Beta1.67